(Q33399309)

English

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy (English)
0 references
0 references
Lauren Pinter-Brown

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit